logo
logo

Blue Note Therapeutics Raises $5.2M In Additional Series A Funding

Sep 09, 2021•almost 4 years ago

Amount Raised

$5.2 Million

Round Type

series a

San Francisco

Description

Blue Note Therapeutics raised an additional $5.2 million in Series A financing, bringing the company's Series A financing to a total of $31 million. The financing was provided by Memorial Sloan Kettering Cancer Center (MSK) and Alumni Ventures who joined Series A lead investors JAZZ Venture Partners and Summer VC.

Company Information

Company

Blue Note Therapeutics

Location

San Francisco, California, United States

About

Blue Note Therapeutics is a prescription digital therapeutics company singularly dedicated to patients suffering from cancer. We aim to make treatment accessible to any cancer patient, at any time, by merging deep scientific and clinical expertise, neuroscience, and digital innovation. Working closely with cancer research and patient communities, we are developing a pipeline of clinically validated prescription digital therapeutics to help reduce anxiety, depression, and other forms of cancer-related distress. For more information, visit www.bluenotetherapeutics.com.